Immunohistochemistry and clinical value of sirtuin 2 in non-metastasized non-small cell lung cancer.

Gao, Cai-Xia; Chen, Bin; Xie, Hui-Kang; Han, Chao-Nan; Luo, Jie

Gao, Cai-Xia; Chen, Bin; Xie, Hui-Kang; Han, Chao-Nan; Luo, Jie.

Afiliación

Gao CX; Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
Chen B; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
Xie HK; Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
Han CN; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
Luo J; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.

J Thorac Dis ; 11(9): 3973-3979, 2019 Sep.

Article en En | MEDLINE | ID: mdl-31656671

Palabras clave

Non-small cell lung cancer (NSCLC); immunohistochemistry; prognosis; sirtuin 2 (SIRT2)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Thorac Dis Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google